Beer TM - Search Results

1

Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical Trial.

Armstrong AJ, Lin P, Higano CS, Iversen P, Sternberg CN, Tombal B, Phung D, Parli T, Krivoshik A, Beer TM. Armstrong AJ, et al. Among authors: beer tm. Eur Urol Oncol. 2019 Nov;2(6):677-684. doi: 10.1016/j.euo.2018.11.005. Epub 2018 Dec 3. Eur Urol Oncol. 2019. PMID: 31274110 Free article. Clinical Trial.

2

Complications of chemotherapy for prostate cancer.

Beer TM, Bubalo JS. Beer TM, et al. Semin Urol Oncol. 2001 Aug;19(3):222-30. Semin Urol Oncol. 2001. PMID: 11561990 Review.

3

Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer.

Beer TM, Pierce WC, Lowe BA, Henner WD. Beer TM, et al. Ann Oncol. 2001 Sep;12(9):1273-9. doi: 10.1023/a:1012258723075. Ann Oncol. 2001. PMID: 11697840 Free article. Clinical Trial.

4

Successful treatment of metastatic hormone-refractory prostate cancer with malignant pericardial tamponade using docetaxel.

Hayes-Lattin BM, Kovach PA, Henner WD, Beer TM. Hayes-Lattin BM, et al. Among authors: beer tm. Urology. 2002 Jan;59(1):137. doi: 10.1016/s0090-4295(01)01481-9. Urology. 2002. PMID: 11796304

5

Effects of docetaxel on pain due to metastatic androgen-independent prostate cancer.

Beer TM, Bubalo JS. Beer TM, et al. Curr Urol Rep. 2002 Jun;3(3):232-8. doi: 10.1007/s11934-002-0070-z. Curr Urol Rep. 2002. PMID: 12084194 Review.

6

Unilateral autonomous testicular testosterone production mimicking androgen independent prostate cancer.

Lavelle M, Schuff KG, Keller FS, Binkert CA, O'Hara M, Fairfax CA, Beer TM. Lavelle M, et al. Among authors: beer tm. J Urol. 2002 Sep;168(3):1098-9. doi: 10.1016/S0022-5347(05)64586-7. J Urol. 2002. PMID: 12187234 No abstract available.

7

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer.

Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD. Beer TM, et al. J Clin Oncol. 2003 Jan 1;21(1):123-8. doi: 10.1200/jco.2003.05.117. J Clin Oncol. 2003. PMID: 12506180 Clinical Trial.

8

Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy.

Beer TM, Garzotto M, Eilers KM, Lemmon D. Beer TM, et al. J Urol. 2003 May;169(5):1738-41. doi: 10.1097/01.ju.0000059584.47272.9d. J Urol. 2003. PMID: 12686821 Clinical Trial.

9

Development of weekly high-dose calcitriol based therapy for prostate cancer.

Beer TM. Beer TM. Urol Oncol. 2003 Sep-Oct;21(5):399-405. doi: 10.1016/s1078-1439(03)00170-4. Urol Oncol. 2003. PMID: 14670552 Review.

10

Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy.

Beer TM, Garzotto M, Eilers KM, Lemmon D, Wersinger EM. Beer TM, et al. Urology. 2004 Feb;63(2):342-7. doi: 10.1016/j.urology.2003.09.045. Urology. 2004. PMID: 14972486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters